Investing

Pharmacogenomic testing, a mature and growing aspect of personalized medicine, has demonstrated significant ability to improve health outcomes and reduce healthcare costs. Since the 1970s, pharmacogenomics has continued to assert significant effectiveness in optimizing clinical care. While current government and commercial efforts to negotiate competitive drug prices are important, this focus represents a secondary and …

Pharmacogenomics: Creating a Better Health System Read More »

This week, a startup company joined forces with one of the nation’s most prestigious health systems to improve care for patients with chronic gastrointestinal conditions. More than 70 million Americans — 25% of the commercially insured population — lives with gastrointestinal conditions such as irritable bowel syndrome or inflammatory bowel disease, which cause unpleasant and …

Mayo Clinic, Ayble Health Team Up Make GI Care Less Complicated Read More »